Chicago Booth Announces New Joint Degree Program in Biomedical Sciences and Business, as well as New MBA Concentration in Healthcare
Booth’s two new offerings provide students with the foundation needed to make a transformative, positive impact on the healthcare system.
- September 07, 2023
The University of Chicago Booth School of Business today announced its new joint MBA/MS Biomedical Sciences program, which gives students the opportunity to pursue both a master in biomedical sciences (BMS) from the University of Chicago and a master of business administration from Chicago Booth. Booth also now offers an MBA concentration in healthcare, designed to equip students with the tools needed to excel in a wide range of in-demand healthcare career paths.
Booth’s newest joint-degree program in biomedical sciences and business is an opportunity for students looking to combine business expertise with foundational knowledge in biomedicine to become leaders and innovators in the healthcare industry. Candidates will take 14 Booth-only courses and LEAD, an experiential leadership development course, as well as six MS-only courses, over the span of the two-year program. The enhanced curriculum pairs leadership and management skills with the research, applied, and clinical skills needed to transform healthcare. Upon completion of the dual-degree program, graduates will be equipped to enter fields such as biotechnology, policy, government, and pharmaceuticals.
The MBA/MS Biomedical Sciences program is one of nine joint-degree options available through Chicago Booth and the University of Chicago to students interested in going beyond the MBA to develop specialized expertise and credentials.